“Award Winning Alerts”
Donate To Hereitfirst!
- Why it's time for investors to go on defense October 4, 2018
- Premarket: 7 things to know before the bell October 4, 2018
- Barnes & Noble stock soars 20% as it explores a sale October 3, 2018
- Toys 'R' Us brand may be brought back to life October 3, 2018
- Honda teams up with GM on self-driving cars October 3, 2018
Tag Archives: afrezza
Its that time of the year again! Earnings season! Notable earnings coming up. Google 4/16 Amazon 4/24 Under Armour 4/24 Apple 4/23 TSLA 5/14. I will most likely put Calls on Google and Amazon. Puts on TSLA ( Tesla) . … Continue reading
Stock Picks For Tomorrow 4-7 -HYSR, HYII, IPRU. HYSR is currently one of our LONG TERM PENNY STOCKS. However during the last few weeks HYSR was way too expensive IMO. Today’s drop put HYSR at an affordable price. HYSR still … Continue reading
Today was a great day but before we begin with our usual post I would like to get a point across to our fan base/ followers. Anyone who has made money from our advice and stock picks we do not … Continue reading
After-hours today MannKind Corp. got a verbal “yes” from the FDA on their inhaled diabetes treatment, Afrezza. FDA approved advisors voted positively for the MNKD drug. Afrezza received a 13 to 1 vote for the drug to be used to … Continue reading
GREAT NEWS ON AFREZZA !! MANNKIND WILL SOAR TOMORROW. Details to come Link to the original article on reuters click here.
As you all may already know shares of MNKD were halted ahead of the AdCom. At Hereitfirst we have been monitoring for the last 4 months. We have come to believe that MNKD will almost certainly be approved for Type … Continue reading
Breaking News Out of MYEC & PHOT ( 2 of our long Term Penny Stocks ) !! Financials are out ! For an analysis on MYEC click here ( MYEC is definitely going to Gap tomorrow) . Great news out of PHOT! … Continue reading
Big Week for our team at Hereitfirst. 3/4 of our analysts have a significant stake in MNKD! If Mannkind’s product Afrezza gets approved during Tuesday’s AdCom, This stock will soar. However if the FDA does not approve MNKD’s product this … Continue reading